Home › Cambridge rare disease biotech Synageva to be acquired for $8.4B
 

Keywords :   


Cambridge rare disease biotech Synageva to be acquired for $8.4B

2015-05-06 13:59:14| Biotech - Topix.net

Cambridge rare disease biotech Synageva BioPharma Corp. will be acquired for $8.4 billion by Connecticut-based Alexion Pharmaceuticals, the two companies announced today.

Tags: disease rare acquired cambridge

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10'Rightmove is my porn' - the addiction to online property search
06.10Eastern North Pacific Tropical Weather Outlook
06.10Atlantic Tropical Weather Outlook
05.10Tropical Storm Milton Public Advisory Number 2
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 26
05.10Tropical Storm Milton Graphics
05.10Hurricane Kirk Wind Speed Probabilities Number 26
More »